Dual Blockade of EGFR Tyrosine Kinase Using Osimertinib and Afatinib Eradicates EGFR‑mutant Ba/F3 Cells

Oncology Reports - Greece
doi 10.3892/or.2018.6881
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications


Related search